Researchers have identified several target molecules which are suitable for the development of new allergy drugs. (sciencedaily.com)
The Pulmonary - Allergy Drugs Advisory Committee of the FDA evaluated the results of a clinical trial of the drug Pulmozyme on 968 patients. (newscientist.com)
-- Kuldeep Dhama — Recent Patents On Inflammation & Allergy Drug Discovery (microbiomedigest.com)